Internal Medicine, Hematology & Oncology · East Brunswick, NJ
NPI
1518165919
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
629 Cranbury Rd Fl 2
East Brunswick, NJ, 08816
Phone (732) 390-7750
Groups this clinician bills Medicare through
Medicare paid, 2024
$445K
19,659 services
Medicare patients, 2024
481
Average age 76
Drug cost, 2024
$1.9M
794 prescriptions
Company payments, 2025
$1,037
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aamer Farooq was code 99232 (hospital e&m - subsequent), 1,369 times for 246 patients. In total Aamer Farooq billed 19,659 services in 90 codes, and Medicare paid $445K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,369 | 246 | $66.29 | $91K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 398 | 13 | $0.09 | $35.6 |
| 99214 Office E&M - Established | Office | 355 | 133 | $104.15 | $37K |
| 88185 Surgical Pathology Examination | Office | 298 | 11 | $21.72 | $6,472 |
| 36415 Venipuncture Blood Collection | Office | 274 | 121 | $8.56 | $2,344 |
| 99222 Hospital E&M - Initial | Facility | 165 | 137 | $110.35 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 165 | 51 | $13.78 | $2,274 |
| 99223 Hospital E&M - Initial | Facility | 151 | 127 | $143.25 | $22K |
| 99214 Office E&M - Established | Facility | 136 | 57 | $81.81 | $11K |
| 85027 Blood Count | Office | 129 | 54 | $6.19 | $799 |
| 85025 Blood Count | Office | 100 | 52 | $7.46 | $746 |
| 96372 Injection Administration | Office | 74 | 26 | $12.09 | $895 |
| 96367 Intravenous Infusion, Hydration | Office | 62 | 18 | $24.47 | $1,517 |
| 99215 Office E&M - Established | Office | 51 | 33 | $150.65 | $7,683 |
| 96413 Chemotherapy Administration | Office | 44 | 18 | $106.41 | $4,682 |
By year: 2022 $1.1M for 84,487 services; 2023 $1.4M for 91,478 services; 2024 $445K for 19,659 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 298 | 11 | $21.72 | $6,472 |
| 36415 Venipuncture Blood Collection | 274 | 121 | $8.56 | $2,344 |
| 85027 Blood Count | 129 | 54 | $6.19 | $799 |
| 85025 Blood Count | 100 | 52 | $7.46 | $746 |
| 88184 Surgical Pathology Examination | 11 | 11 | $71.50 | $787 |
Medicare prescription drug claims, 2024
In 2024, the drug Aamer Farooq prescribed most often to Medicare patients was Eliquis (Apixaban), with 69 prescriptions and refills. In total Aamer Farooq wrote 794 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 69 | 94 | 20 | $54K |
| Aranesp Darbepoetin Alfa In Polysorbat | 66 | 66 | 25 | $206K |
| Letrozole Generic | 34 | 58 | Under 11 | $474 |
| Oxycodone Hcl Generic | 32 | 32 | 16 | $467 |
| Prednisone Generic | 31 | 35 | 19 | $61.28 |
| Neulasta Pegfilgrastim | 27 | 27 | Under 11 | $281K |
| Ondansetron Odt Ondansetron | 26 | 26 | 16 | $2,141 |
| Imatinib Mesylate Generic | 17 | 17 | Under 11 | $2,790 |
| Xgeva Denosumab | 17 | 17 | Under 11 | $54K |
| Ontruzant Trastuzumab-Dttb | 16 | 16 | Under 11 | $62K |
| Potassium Chloride Generic | 15 | 15 | Under 11 | $21.65 |
| Dexamethasone Generic | 14 | 20 | Under 11 | $373 |
| Xtandi Enzalutamide | 13 | 13 | Under 11 | $179K |
| Promacta Eltrombopag Olamine | 12 | 12 | Under 11 | $159K |
| Megestrol Acetate Generic | 12 | 12 | Under 11 | $202 |
Brand drugs: 329 claims; generic drugs: 465 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aamer Farooq $1,037 ($1,037 in general payments such as food, travel and fees) from 25 companies. The largest payer was Karyopharm Therapeutics Inc. with $271.
| Company | Payments | Amount |
|---|---|---|
| Karyopharm Therapeutics Inc. KPTI | 2 | $271 |
| Daiichi Sankyo Inc. 4568.T | 3 | $66.09 |
| Eisai Inc. 4523.T | 3 | $59.2 |
| GlaxoSmithKline, LLC. GSK | 3 | $57.76 |
| Janssen Biotech, Inc. JNJ | 3 | $56.6 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $55.87 |
| Tempus AI, Inc TEM | 2 | $47.53 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $41.94 |
| Astellas Pharma US Inc 4503.T | 2 | $38.12 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $36.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.